New HIV treatment launched in the UK

Raltegravir (ISENTRESS) 600mg has been launched in the UK for the treatment of HIV-1 infection in adults and paediatric patients (weighing at least 40kg), who are treatment-naïve or whose virus has been virologically suppressed on an initial regimen of raltegravir 400 mg twice daily, MSD UK has announced. The treatment provides a new 1,200mg once-daily treatment, administered as two 600mg tablets with or without food, in combination with other antiretroviral medicinal products. The news follows approval by the European Commission in July which allows marketing of once-daily raltegravir 600mg in the 28-member countries of the European Union, as well as